The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Impact of T and N Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer: A Pooled Analysis Oral Presentation at the 39th Annual Meeting of the American Society of Clinical Oncology in Colorectal Cancer Session, Chicago, IL, June 1, 2003.Authors’ disclosures of potential conflicts of interest are found at the end of this article.
Open accessAbstract
Purpose: To determine survival and relapse rates by T and N stage and treatment method in five randomized phase III North American rectal adjuvant studies. Patients and Methods: Data were pooled from 3,791 eligible patients enrolled onto North Central Cancer Treatment Group (NCCTG) 79-47-51, NCCTG 86-47-51, US Gastrointestinal Intergroup 0114, National Surgical Adjuvant Breast and Bowel Project (NSABP) R01, and NSABP R02. Surgery alone (S) was the treatment arm in 179 patients. The remaining patients received adjuvant treatment as follows: irradiation (RT) alone (n = 281), RT + fluorouracil (FU) ± semustine bolus chemotherapy (CT; n = 779), RT + protracted venous infusion CT (n = 325), RT + FU ± leucovorin or levamisole bolus CT (n = 1,695), or CT alone (n = 532). Five-year follow-up was available in 94% of surviving patients, and 8-year follow-up, in 62%. Results: Overall (OS) and disease-free survival were dependent on TN stage, NT stage, and treatment method. Even among N2 patients, T substage influenced 5-year OS (T1-2, 67%; T3, 44%; T4, 37%; P < .001). Three risk groups of patients were defined: (1) intermediate (T1-2/N1, T3/N0), (2) moderately high (T1-2/N2, T3/N1, T4/N0), and (3) high (T3/N2, T4/N1, T4/N2). For intermediate-risk patients, those receiving S plus CT had 5-year OS rates of 85% (T1-2/N1) and 84% (T3/N0), which was similar to results with S plus RT plus CT (T1-2/N1, 78% to 83%; T3/N0, 74% to 80%). For moderately high-risk lesions, 5-year OS ranged from 43% to 70% with S plus CT, and 44% to 80% with S plus RT plus CT. For high-risk lesions, 5-year OS ranged from 25% to 45% with S plus CT, and 29% to 57% with S plus RT plus CT. Conclusion: Different treatment strategies may be indicated for intermediate-risk versus moderately high- or high-risk patients based on differential survival rates and rates of relapse. Use of trimodality treatment for all patients with intermediate-risk lesions may be excessive, since S plus CT resulted in 5-year OS of approximately 85%; however, 5-year disease-free survival rates with S plus CT were 78% (T1-2/N1) and 69%(T3/N0), indicating room for improvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010580 · Cited by 4,205
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
AJCC Cancer Staging Manual. 6th ed
Greene, F., Page, D., Id, F., Fritz, J., Balch, C., & Haller, D. (2002) · Cited by 2,324
Self-citationLevamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220602 · Cited by 2,256
Self-citationLOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION
Quirke, P., Dixon, M. F., Durdey, P., & Williams, N. S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92612-7 · Cited by 1,973
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
Krook, J. E., Moertel, C. G., Gunderson, L. L., Wieand, H. S., Collins, R. T., Beart, R. W., Kubista, T. P., Poon, M. A., Meyers, W. C., Mailliard, J. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103143241101 · Cited by 1,879
Self-citationMesorectal excision for rectal cancer
MacFarlane, J. K., Ryall, R. D. H., & Heald, R. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90207-w · Cited by 1,781
O'Connell, M. J., Martenson, J. A., Wieand, H. S., Krook, J. E., Macdonald, J. S., Haller, D. G., Mayer, R. J., Gunderson, L. L., & Rich, T. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310803 · Cited by 1,136
Self-citationProlongation of the Disease-Free Interval in Surgically Treated Rectal Carcinoma
Gastrointestinal Tumor Study Group (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122301 · Cited by 1,130
THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM
Astler, V. B., & Coller, F. A. (1954) · Annals of Surgery · doi:10.1097/00000658-195406000-00015 · Cited by 1,104
Adjuvant Therapy for Patients With Colon and Rectal Cancer
(1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03450110090034 · Cited by 1,086
Role of circumferential margin involvement in the local recurrence of rectal cancer
Adam, I. J., Martin, I. G., Finan, P., Johnston, D., Mohamdee, M. O., Scott, N., Dixon, M. F., & Quirke, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92206-3 · Cited by 1,036
Fisher, B., Wolmark, N., Rockette, H., Redmond, C., Deutsch, M., Wickerham, D. L., Fisher, E. R., Caplan, R., Jones, J., Lerner, H., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.21 · Cited by 1,030
Self-citationMoertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-5-199503010-00001 · Cited by 925
Self-citation(1995) · PubMed · Cited by 759
Gunderson, L. L., & Sosin, H. (1974) · Cancer · doi:10.1002/1097-0142(197410)34:4<1278::aid-cncr2820340440>3.0.co;2-f · Cited by 750
Self-citationLaurie, J. A., Moertel, C. G., Fleming, T. R., Wieand, H. S., Leigh, J. E., Rubin, J., McCormack, G. W., Gerstner, J. B., Krook, J. E., & Malliard, J. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.10.1447 · Cited by 700
Wolmark, N., Rockette, H., Fisher, B., Wickerham, D. L., Redmond, C., Fisher, E. R., Jones, J., Mamounas, E. P., Ore, L., & Petrelli, N. J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1879 · Cited by 689
Self-citationO'Connell, M. J., Mailliard, J. A., Kahn, M. J., Macdonald, J. S., Haller, D. G., Mayer, R. J., & Wieand, H. S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.246 · Cited by 585
Self-citationImpact of Number of Nodes Retrieved on Outcome in Patients With Rectal Cancer
Tepper, J. E., O’Connell, M. J., Niedzwiecki, D., Hollis, D., Compton, C., Benson, A. B., Cummings, B., Gunderson, L., Macdonald, J. S., & Mayer, R. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.157 · Cited by 560
Self-citationWolmark, N. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.5.388 · Cited by 530
Self-citationSurvival after Postoperative Combination Treatment of Rectal Cancer
(1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152014 · Cited by 529
Riethmüller, G., Holz, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber, R., Funke, I., Pichlmaier, H., Hirche, H., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1788 · Cited by 517
O'Connell, M. J., Laurie, J. A., Kahn, M., Fitzgibbons, R. J., Erlichman, C., Shepherd, L., Moertel, C. G., Kocha, W. I., Pazdur, R., Wieand, H. S., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.295 · Cited by 417
Self-citationCompton, C. C., Byrd, D. R., Garcia-Aguilar, J., Kurtzman, S. H., Olawaiye, A., & Washington, M. K. (2012) · AJCC Cancer Staging Atlas · doi:10.1007/978-1-4614-2080-4_14 · Cited by 395
Hyams, D. M., Mamounas, E. P., Petrelli, N., Rockette, H., Jones, J., Wieand, S. H., Deutsch, M., Wickerham, L. D., Fisher, B., & Wolmark, N. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02054976 · Cited by 360
Self-citationTepper, J. E., O’Connell, M., Niedzwiecki, D., Hollis, D. R., Benson, A. B., Cummings, B., Gunderson, L. L., Macdonald, J. S., Martenson, J. A., & Mayer, R. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.132 · Cited by 321
Self-citationMarijnen, C. A. M., Nagtegaal, I. D., Kapiteijn, E., Kranenbarg, E. K., Noordijk, E. M., van Krieken, J. H. J. M., van de Velde, C. J. H., & Leer, J. W. H. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04291-8 · Cited by 261
Failure Patterns Following Curative Resection of Colonic Carcinoma
WILLETT, C. G., TEPPER, J. E., COHEN, A. M., ORLOW, E., & WELCH, C. E. (1984) · Annals of Surgery · doi:10.1097/00000658-198412000-00001 · Cited by 256
Self-citationWillett, C. G., Badizadegan, K., Ancukiewicz, M., & Shellito, P. C. (1999) · Diseases of the Colon & Rectum · doi:10.1007/bf02237122 · Cited by 253
Self-citationTepper, J. E., O'Connell, M. J., Petroni, G. R., Hollis, D., Cooke, E., Benson, A. B., Cummings, B., Gunderson, L. L., Macdonald, J. S., & Martenson, J. A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.2030 · Cited by 250
Self-citationGrann, A., Minsky, B. D., Cohen, A. M., Saltz, L., Guillem, J. G., Paty, P. B., Kelsen, D. P., Kemeny, N., Ilson, D., & Bass-Loeb, J. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02055370 · Cited by 237
Tveit, K. M., Guldvog, I., Hagen, S., Trondsen, E., Harbitz, T., Nygaard, K., Nilsen, J. B., Wist, E., & On behalf of the Norwegian adjuvant Rectal Cancer Project Group (1997) · British Journal of Surgery · doi:10.1002/bjs.1800840827 · Cited by 229
(1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.4.549 · Cited by 205
WOLMARK, N., FISHER, B., & WIEAND, H. S. (1986) · Annals of Surgery · doi:10.1097/00000658-198602000-00001 · Cited by 201
Self-citationMohiuddin, M., Hayne, M., Regine, W. F., Hanna, N., Hagihara, P. F., McGrath, P., & Marks, G. M. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00732-x · Cited by 170
Gunderson, L. L., Sargent, D. J., Tepper, J. E., O’Connell, M. J., Allmer, C., Smalley, S. R., Martenson, J. A., Haller, D. G., Mayer, R. J., Rich, T. A., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02945-0 · Cited by 150
Self-citationSauer, R., Fietkau, R., Wittekind, C., Martus, P., Rödel, C. M., Hohenberger, W., Jatzko, G. R., Sabitzer, H., Karstens, J.-H., Heinz Becker, A., et al. (2001) · Strahlentherapie und Onkologie · doi:10.1007/pl00002396 · Cited by 129
Tveit, K. M., Guldvog, I., Hagen, S., et al. (1997) · PubMed · Cited by 121
Wolmark, N., Smith, R. P., Fisher, B., Bryant, J., Hyams, D. M., Atkins, J., Dimitrov, N. S., Oishi, R. H., Prager, D., Fehrenbacher, L., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1810 · Cited by 101
Self-citationValentini, V., Coco, C., Cellini, N., Picciocchi, A., Rosetto, M. E., Mantini, G., MARMIROLI, L., Barbaro, B., Cogliandolo, S., Nuzzo, G., et al. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00301-6 · Cited by 80
Goldberg, R. M., Sargent, D. J., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B., Pitot, H., & Alberts, S. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3621 · Cited by 70
Self-citationPathologic downstaging of T3–4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur
Calvo, F. Á., Gómez-Espí, M., Díaz-González, J. A., del Pie, R. C., Marcos, P., Alvarado, A., Alfonso, P., Herranz, R., & Álvarez, E. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01728-x · Cited by 43
Indications for and Results of Combined Modality Treatment of Colorectal Cancer
Gunderson, L. L. (1999) · Acta Oncologica · doi:10.1080/028418699431753 · Cited by 34
Self-citationSphincter Preservation for Rectal Cancer: Fact or Fiction?
Minsky, B. D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.8.1971 · Cited by 17
Postoperative adjuvant irradiation with or without chemotherapy for rectal carcinoma
Gunderson, L. L., & Martenson, J. A. (1993) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(05)80078-5 · Cited by 10
Self-citation
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Weitz, J., Koch, M., Debus, J., Höhler, T., Galle, P. R., & Büchler, M. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17706-x · Cited by 1,098
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0061 · Cited by 944
Self-citationRevised TN Categorization for Colon Cancer Based on National Survival Outcomes Data
Gunderson, L. L., Jessup, J. M., Sargent, D. J., Greene, F. L., & Stewart, A. K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.0952 · Cited by 603
Self-citationChau, I., Brown, G., Cunningham, D., Tait, D., Wotherspoon, A., Norman, A. R., Tebbutt, N., Hill, M., Ross, P. J., Massey, A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4875 · Cited by 474
Metadata
- Authors
- Gunderson, L. L., Sargent, D. J., Tepper, J. E., Wolmark, N., O'Connell, M. J., Begovic, M., Allmer, C., Colangelo, L., Smalley, S. R., Haller, D. G., Martenson, J. A., Mayer, R. J., Rich, T. A., Ajani, J. A., MacDonald, J. S., Willett, C. G., & Goldberg, R. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2004-05-15
- Volume
- 22
- Issue
- 10
- Pages
- 1785-1796
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2168323176
- Cited by
- 436
- References
- 50
- FWCI
- 11.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.